GLP-1 medications reduce physical hunger but do not directly treat binge eating behaviors, emotional eating triggers, or psychological factors that contribute to overeating
Weight reduction most likely played a large role in heart health, but researchers are also finding convincing early evidence that GLP-1and the drugsmay reduce inflammation when bound to receptors
Experimental patches typically deliver 1030% of injected doses due to peptide size and skin absorption limits
As we dive into todays episode, as always innovating and integrating in the world of womens health
Common GLP-1 Inhibitors Some of the most commonly prescribed GLP-1 inhibitors include: Semaglutide (Ozempic, Wegovy, Rybelsus) Liraglutide (Victoza, Saxenda) Dulaglutide (Trulicity) Tirzepatide (Mounjaro) Exenatide (Byetta, Bydureon) These medications are most commonly administered in the form of weekly injections, but there are a few oral formulations available on the market as well